Malignant cancers include ovarian cancer teratocarcinoma. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy15

Cell Line, Tumor Embryonal Carcinoma Stem Cells Tumor Cells, Cultured Cell Line Neoplastic Stem Cells Endoderm Hybrid Cells Clone Cells Blastocyst Ovary Breast Embryo, Mammalian Cells, Cultured Epithelial Cells Prostate

Organisms4

Mice, Nude Mice, Inbred BALB C Mice, SCID Retroviridae

Diseases56

Teratocarcinoma Neoplasms Teratoma Ovarian Neoplasms Cell Transformation, Neoplastic Neoplasms, Glandular and Epithelial Breast Neoplasms Cystadenocarcinoma, Serous Neoplasm Invasiveness Prostatic Neoplasms Neoplasms, Experimental Carcinoma Lung Neoplasms Neoplasm Metastasis Testicular Neoplasms Colonic Neoplasms Stomach Neoplasms Genetic Predisposition to Disease Pancreatic Neoplasms Adenocarcinoma, Clear Cell Disease Progression Carcinoma, Endometrioid Peritoneal Neoplasms Neoplasm Recurrence, Local Uterine Cervical Neoplasms Adenocarcinoma, Mucinous Endometrial Neoplasms Ascites Colorectal Neoplasms Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Urinary Bladder Neoplasms Genital Neoplasms, Female Rectal Neoplasms Adenocarcinoma Cystadenocarcinoma Neoplastic Syndromes, Hereditary Neovascularization, Pathologic Fallopian Tube Neoplasms Esophageal Neoplasms Liver Neoplasms Neoplasms, Cystic, Mucinous, and Serous Neoplasms, Second Primary Carcinoma, Embryonal Head and Neck Neoplasms Neoplasms, Hormone-Dependent Carcinoma, Small Cell Hereditary Breast and Ovarian Cancer Syndrome Mouth Neoplasms Neoplasms, Multiple Primary Precancerous Conditions Neoplasms, Radiation-Induced Breast Neoplasms, Male Bone Neoplasms Gastrointestinal Neoplasms Cystadenocarcinoma, Mucinous

Chemicals and Drugs61

Tretinoin CA-125 Antigen RNA, Messenger Neoplasm Proteins Antineoplastic Agents Tumor Markers, Biological DNA, Neoplasm Cisplatin Antigens, Neoplasm Paclitaxel Bucladesine RNA, Neoplasm Cancer Vaccines BRCA2 Protein BRCA1 Protein Antigens, CD15 Antineoplastic Agents, Phytogenic RNA, Small Interfering Antibodies, Monoclonal Receptor, erbB-2 Receptors, Estrogen Transcription Factors DNA-Binding Proteins Tumor Suppressor Protein p53 Carboplatin Beta-Globulins Growth Differentiation Factor 3 Nuclear Proteins Receptors, Retinoic Acid Proto-Oncogene Proteins Epididymal Secretory Proteins DNA Prostate-Specific Antigen Receptors, Progesterone Tamoxifen Uridine Diphosphate N-Acetylgalactosamine Fluorouracil MicroRNAs Receptor, Epidermal Growth Factor Tumor Suppressor Proteins HSP47 Heat-Shock Proteins Antineoplastic Agents, Hormonal Taxoids Membrane Proteins Anticarcinogenic Agents Carrier Proteins Platinum Deoxycytidine Glycoproteins Proto-Oncogene Proteins c-akt Antigens, Tumor-Associated, Carbohydrate Organoplatinum Compounds Laminin Glucose-6-Phosphate Isomerase Antimetabolites, Antineoplastic Antibodies, Monoclonal, Humanized Platinum Compounds Topotecan Butyric Acid Estrogens Receptors, Androgen

Analytical, Diagnostic and Therapeutic Techniques and Equipment61

Early Detection of Cancer Neoplasms, Experimental Neoplasm Transplantation Prognosis Neoplasm Staging Survival Analysis Antineoplastic Combined Chemotherapy Protocols Xenograft Model Antitumor Assays Survival Rate Reverse Transcriptase Polymerase Chain Reaction Transfection Blotting, Western Gene Expression Profiling Risk Disease-Free Survival Retrospective Studies Follow-Up Studies Prospective Studies Risk Factors Registries Risk Assessment Polymerase Chain Reaction Odds Ratio Combined Modality Therapy Transplantation, Heterologous Sensitivity and Specificity Oligonucleotide Array Sequence Analysis Kaplan-Meier Estimate Drug Screening Assays, Antitumor Genetic Testing Chemotherapy, Adjuvant Multivariate Analysis Tumor Burden Immunohistochemistry Tissue Array Analysis Questionnaires Neoplasm Grading SEER Program Molecular Targeted Therapy Treatment Outcome Clinical Trials as Topic Predictive Value of Tests Nucleic Acid Hybridization Logistic Models Drug Administration Schedule Reproducibility of Results Mammography Cloning, Molecular Confidence Intervals Blotting, Northern Gene Knockdown Techniques Incidence DNA Mutational Analysis Flow Cytometry Immunoenzyme Techniques Fluorescent Antibody Technique Models, Biological Cohort Studies Radiotherapy Immunotherapy Genetic Therapy

Psychiatry and Psychology1

Phenomena and Processes52

Gene Expression Regulation, Neoplastic Cell Differentiation Genes, BRCA1 Drug Resistance, Neoplasm Genetic Predisposition to Disease Mutation Base Sequence Genes, BRCA2 Transfection Promoter Regions, Genetic Transcription, Genetic Risk Cell Division Germ-Line Mutation Cell Proliferation DNA Methylation Apoptosis Odds Ratio Cell Survival Gene Expression Sensitivity and Specificity Cell Movement Phenotype Genotype Down-Regulation Cell Growth Processes Amino Acid Sequence Cell Cycle Dose-Response Relationship, Drug Up-Regulation Genes, Tumor Suppressor Polymorphism, Genetic RNA Interference Cell Adhesion Signal Transduction Gene Silencing Gene Expression Regulation Nucleic Acid Hybridization Genes, Neoplasm Time Factors Cell Aggregation Genes, p53 Postmenopause Drug Synergism Heterozygote Alleles Phosphorylation Diet Loss of Heterozygosity Tumor Microenvironment Genes Methylation

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science8

Base Sequence Molecular Sequence Data Survival Rate Registries Amino Acid Sequence Questionnaires SEER Program Incidence

Named Groups1

Health Care28

Survival Analysis Survival Rate Risk Disease-Free Survival Retrospective Studies Follow-Up Studies Prospective Studies Risk Factors Registries Risk Assessment Odds Ratio National Cancer Institute (U.S.)Age Factors Sensitivity and Specificity Kaplan-Meier Estimate Genetic Testing Multivariate Analysis Questionnaires SEER Program Treatment Outcome Clinical Trials as Topic Predictive Value of Tests Logistic Models Reproducibility of Results Confidence Intervals Incidence American Cancer Society Cohort Studies

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Teratocarcinoma Neoplasms Teratoma Ovarian Neoplasms Cell Transformation, Neoplastic Cell Line, Tumor Embryonal Carcinoma Stem Cells Neoplasms, Glandular and Epithelial Tretinoin Early Detection of Cancer Tumor Cells, Cultured Gene Expression Regulation, Neoplastic Cell Differentiation CA-125 Antigen Breast Neoplasms Cystadenocarcinoma, Serous Genes, BRCA1 RNA, Messenger Neoplasm Proteins Antineoplastic Agents Neoplasm Invasiveness Prostatic Neoplasms Mice, Nude Neoplasms, Experimental Drug Resistance, Neoplasm Cell Line Carcinoma Lung Neoplasms Neoplasm Metastasis Testicular Neoplasms Neoplasm Transplantation Tumor Markers, Biological Colonic Neoplasms DNA, Neoplasm Stomach Neoplasms Prognosis Neoplastic Stem Cells Neoplasm Staging Genetic Predisposition to Disease Mutation Survival Analysis Cisplatin Antineoplastic Combined Chemotherapy Protocols Antigens, Neoplasm Base Sequence Paclitaxel Molecular Sequence Data Genes, BRCA2 Bucladesine Xenograft Model Antitumor Assays Pancreatic Neoplasms Survival Rate RNA, Neoplasm Cancer Vaccines Reverse Transcriptase Polymerase Chain Reaction BRCA2 Protein Transfection Blotting, Western Gene Expression Profiling Adenocarcinoma, Clear Cell BRCA1 Protein Disease Progression Promoter Regions, Genetic Transcription, Genetic Risk Carcinoma, Endometrioid Cell Division Antigens, CD15 Peritoneal Neoplasms Neoplasm Recurrence, Local Uterine Cervical Neoplasms Disease-Free Survival Adenocarcinoma, Mucinous Endoderm Retrospective Studies Follow-Up Studies Endometrial Neoplasms Antineoplastic Agents, Phytogenic Prospective Studies Germ-Line Mutation Cell Proliferation RNA, Small Interfering Risk Factors Registries Antibodies, Monoclonal Ascites Receptor, erbB-2 Risk Assessment Colorectal Neoplasms Receptors, Estrogen Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Polymerase Chain Reaction DNA Methylation Urinary Bladder Neoplasms Hybrid Cells Apoptosis Odds Ratio Transcription Factors Cell Survival

No FAQ available that match "malignant cancers include ovarian cancer teratocarcinoma"